Cargando…

Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review

PURPOSE: Dyskinesia-hyperpyrexia syndrome (DHS) is a rare but life-threatening disease. The clinical manifestations of this syndrome overlap substantially with Parkinson hyperpyrexia syndrome and serotonin syndrome and are often confused by clinicians. The purpose of this review was to enable clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Miao, Wang, Wei, Gao, Zhongbao, Yin, Xi, Chen, Tong, Jiang, Ziying, Wang, Zhenfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292264/
https://www.ncbi.nlm.nih.gov/pubmed/33826041
http://dx.doi.org/10.1007/s10286-021-00801-w
_version_ 1783724794641907712
author Wang, Miao
Wang, Wei
Gao, Zhongbao
Yin, Xi
Chen, Tong
Jiang, Ziying
Wang, Zhenfu
author_facet Wang, Miao
Wang, Wei
Gao, Zhongbao
Yin, Xi
Chen, Tong
Jiang, Ziying
Wang, Zhenfu
author_sort Wang, Miao
collection PubMed
description PURPOSE: Dyskinesia-hyperpyrexia syndrome (DHS) is a rare but life-threatening disease. The clinical manifestations of this syndrome overlap substantially with Parkinson hyperpyrexia syndrome and serotonin syndrome and are often confused by clinicians. The purpose of this review was to enable clinicians to recognize this syndrome and thereby reach a correct diagnosis and provide optimal treatments to improve prognosis in clinical practice. METHODS: Using the methodology described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, we conducted a literature search of the PubMed, Embase, and MEDLINE databases using keywords in titles and abstracts of published literature. Quality assessment was performed using the modified Newcastle-Ottawa scale. RESULTS: A total of 11 patients obtained from nine publications were included in this systematic review. All of the cases occurred in patients with advanced Parkinson's disease (PD) of long disease duration. High ambient temperature was the most common trigger of this syndrome. Hyperpyrexia and dyskinesias were present in all cases. The consciousness disturbances of this syndrome included confusion, hallucination, and lethargy or stupor. Autonomic dysfunction (except for hyperpyrexia) is uncommon in DHS, and only two patients presented with tachycardia. The treatment of this syndrome included supportive interventions (including rehydration, anti-pyretic and anti-infection treatments, and maintaining electrolyte balance), dopaminergic drug reduction and sedation. Two patients died due to DHS. CONCLUSIONS: We summarized the triggers, clinical features, and treatments of all reported dyskinesia-hyperpyrexia syndrome cases, proposed guiding diagnostic criteria, and established a flow chart to guide diagnoses to quickly identify these three syndromes in clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10286-021-00801-w.
format Online
Article
Text
id pubmed-8292264
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82922642021-07-23 Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review Wang, Miao Wang, Wei Gao, Zhongbao Yin, Xi Chen, Tong Jiang, Ziying Wang, Zhenfu Clin Auton Res Review Article PURPOSE: Dyskinesia-hyperpyrexia syndrome (DHS) is a rare but life-threatening disease. The clinical manifestations of this syndrome overlap substantially with Parkinson hyperpyrexia syndrome and serotonin syndrome and are often confused by clinicians. The purpose of this review was to enable clinicians to recognize this syndrome and thereby reach a correct diagnosis and provide optimal treatments to improve prognosis in clinical practice. METHODS: Using the methodology described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, we conducted a literature search of the PubMed, Embase, and MEDLINE databases using keywords in titles and abstracts of published literature. Quality assessment was performed using the modified Newcastle-Ottawa scale. RESULTS: A total of 11 patients obtained from nine publications were included in this systematic review. All of the cases occurred in patients with advanced Parkinson's disease (PD) of long disease duration. High ambient temperature was the most common trigger of this syndrome. Hyperpyrexia and dyskinesias were present in all cases. The consciousness disturbances of this syndrome included confusion, hallucination, and lethargy or stupor. Autonomic dysfunction (except for hyperpyrexia) is uncommon in DHS, and only two patients presented with tachycardia. The treatment of this syndrome included supportive interventions (including rehydration, anti-pyretic and anti-infection treatments, and maintaining electrolyte balance), dopaminergic drug reduction and sedation. Two patients died due to DHS. CONCLUSIONS: We summarized the triggers, clinical features, and treatments of all reported dyskinesia-hyperpyrexia syndrome cases, proposed guiding diagnostic criteria, and established a flow chart to guide diagnoses to quickly identify these three syndromes in clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10286-021-00801-w. Springer Berlin Heidelberg 2021-04-07 2021 /pmc/articles/PMC8292264/ /pubmed/33826041 http://dx.doi.org/10.1007/s10286-021-00801-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Wang, Miao
Wang, Wei
Gao, Zhongbao
Yin, Xi
Chen, Tong
Jiang, Ziying
Wang, Zhenfu
Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
title Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
title_full Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
title_fullStr Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
title_full_unstemmed Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
title_short Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
title_sort dyskinesia-hyperpyrexia syndrome in parkinson’s disease: a systematic review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292264/
https://www.ncbi.nlm.nih.gov/pubmed/33826041
http://dx.doi.org/10.1007/s10286-021-00801-w
work_keys_str_mv AT wangmiao dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview
AT wangwei dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview
AT gaozhongbao dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview
AT yinxi dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview
AT chentong dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview
AT jiangziying dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview
AT wangzhenfu dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview